Study of Ascending Levels of Tolvaptan in Hyponatremia - SALT 1 and 2 – Presented at AHA 2006

Description:

The goal of the trials was to evaluate treatment with tolvaptan, a selective oral vasopressin V2-receptor antagonist, compared with placebo among patients with euvolemic or hypervolemic hyponatremia.